Медицинская литература. Новинки

 

 

 

 

 

 

Скрининговое обследование сердца плода: руководство по выполнению ''базисного'' и ''расширенного'' исследования

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Ferencz C., Rubin J.D., McCarter R.J., Brenner J.I.,
Neill C.A., Perry L.W., Hepner S.I., Downing J.W.
Congenital heart disease: prevalence at livebirth.
The Baltimore–Washington infant study // Am. J.
Epidemiol. 1985. V. 121. № 1. P. 31–36.
2. Meberg A., Otterstad J.E., Froland G., Lindberg H., Sorland S.J. Outcome of congenital heart
defects – a populationbased study // Acta Paediatr. 2000. V. 89. № 11. P. 1344–1351.
3. Cuneo B.F., Curran L.F., Davis N., Elrad H. Trends
in prenatal diagnosis of critical cardiac defects in
an integrated obstetric and pediatric cardiac imaging center // J. Perinatol. 2004. V. 24. № 11.
P. 674–678.
4. Rosano A., Botto L.D., Botting B., Mastroiacovo P.
Infant mortality and congenital anomalies from
1950 to 1994: an international perspective // J.
Epidemiol. Community Health. 2000. V. 54. № 9.
P. 660–666.
5. Crane J.P., LeFevre M.L., Winborn R.C.,
Evans J.K., Ewigman B.G., Bain R.P., Frigoletto F.D., McNellis D. A randomized trial of prenatal ultrasonographic screening: impact on the
detection, management, and outcome of anomalous
fetuses. The RADIUS Study Group // Am. J.
Obstet. Gynecol. 1994. V. 171. № 2. P. 392–399.
6. AbuHarb M., Hey E., Wren C. Death in infancy
from unrecognised congenital heart disease //
Arch. Dis. Child. 1994. V. 71. № 1. P. 3–7.
7. Bonnet D., Coltri A., Butera G., Fermont L.,
Le Bidois J., Kachaner J., Sidi D. Detection of
transposition of the great arteries in fetuses
reduces neonatal morbidity and mortality //
Circulation. 1999. V. 99. № 7. P. 916–918.
8. Tworetzky W., McElhinney D.B., Reddy V.M.,
Brook M.M., Hanley F.L., Silverman N.H. Improved surgical outcome after fetal diagnosis of
hypoplastic left heart syndrome // Circulation.
2001. V. 103. № 9. P. 1269–1273.
9. Andrews R., Tulloh R., Sharland G., Simpson J.,
Rollings S., Baker E., Qureshi S., Rosenthal E.,
Austin C., Anderson D. Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis // Arch. Dis.
Child. 2001. V. 85. № 6. P. 474–477. Erratum in
Arch. Dis. Child. 2002. V. 86. № 4. P. 313.
10. Franklin O., Burch M., Manning N., Sleeman K.,
Gould S., Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduce
morbidity // Heart. 2002. V. 87. № 1. P. 67–69.
11. Tworetzky W., WilkinsHaug L., Jennings R.W.,
van der Velde M.E., Marshall A.C., Marx G.R.,
Colan S.D., Benson C.B., Lock J.E., Perry S.B.
Balloon dilation of severe aortic stenosis in the
fetus: potential for prevention of hypoplastic left
heart syndrome: candidate selection, technique,
and results of successful intervention //
Circulation. 2004. V. 110. № 15. P. 2125–2131.
12. Simpson L.L. Screening for congenital heart disease // Obstet. Gynecol. Clin. North Am. 2004. V. 31.
№1. P. 51–59.
13. DeVore G.R., Medearis A.L., Bear M.B., Horenstein J., Platt L.D. Fetal echocardiography: factors
that influence imaging of the fetal heart during the
second trimester of pregnancy // J. Ultrasound
Med. 1993. V. 12. № 11. P. 659–663.
14. Sharland G.K., Allan L.D. Screening for congenital
heart disease prenatally. Results of a 2 1/2-year
study in the South East Thames Region // Br. J.
Obstet. Gynaecol. 1992. V. 99. № 3. P. 220–225.
15. Carvalho J.S., Mavrides E., Shinebourne E.A.,
Campbell S., Thilaganathan B. Improving the effectiveness of routine prenatal screening for major
congenital heart defects // Heart. 2002. V. 88. № 4.
P. 387–391.
16. Hunter S., Heads A., Wyllie J., Robson S. Prenatal
diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers // Heart.
2000. V. 84. № 3. P. 294–298.
17. Lee W. American Institute of Ultrasound in
Medicine. Performance of the basic fetal cardiac
ultrasound examination // J. Ultrasound Med.
1998. V. 17. № 9. P. 601–607. Erratum in J.
Ultrasound Med. 1998. V. 17. № 12. P. 796.
18. American Institute of Ultrasound in Medicine.
AIUM Practice Guideline for the performance of an
antepartum obstetric ultrasound examination // J.
Ultrasound Med. 2003. V. 22. № 10. P. 1116–1125.
19. American College of Radiology. ACR practice guideline for the performance of antepartum obstetrical
ultrasound // Practice Guidelines & Technical
Standards. Reston, VA: ACR, 2004. P. 689–695.
20. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Ultrasonography
in pregnancy// Obstet. Gynecol. 2004. V. 104. № 6.
P. 1449–1458.
21. Achiron R., Rotstein Z., Lipitz S., Mashiach S.,
Hegesh J. Firsttrimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography //
Obstet. Gynecol. 1994. V. 84. № 1. P. 69–72.
22. Yagel S., Weissman A., Rotstein Z., Manor M.,
Hegesh J., Anteby E., Lipitz S., Achiron R.
Congenital heart defects: natural course and in utero
development // Circulation. 1997. V. 96. № 2.
P. 550–555.
23. Rustico M.A., Benettoni A., D’Ottavio G., Fischer-Tamaro L., Conoscenti G.C., Meir Y., Natale R.,
Bussani R., Mandruzzato G.P. Early screening for
fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of
operator experience // Ultrasound Obstet. Gynecol.
2000. V. 16. № 7. P. 614–619.
24. Carvalho J.S. Fetal heart scanning in the first
trimester // Prenat. Diagn. 2004. V. 24. № 13.
P. 1060–1067.
25. Carvalho J.S., Moscoso G., Tekay A., Campbell S.,
Thilganathan B., Shinebourne E.A. Clinical impact
of first and early second trimester fetal echocardiography on high risk pregnancies // Heart. 2004.
V. 90. № 8. P. 921–926.
26. Huggon I.C., Ghi T., Cook A.C., Zosmer N.,
Allan L.D., Nicolaides K.H. Fetal cardiac abnormalities identified prior to 14 weeks’ gestation //
Ultrasound Obstet. Gynecol. 2002. V. 20. № 1.
P. 22–29.
27. Schwarzler P., Senat M.V., Holden D., Bernard J.P.,
Masroor T., Ville Y. Feasibility of the secondtrimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy:
a randomized trial // Ultrasound Obstet. Gynecol.
1999. V. 14. № 2. P. 92–97.
28. Tegnander E., EikNes S.H., Johansen O.J., Linker D.T. Prenatal detection of heart defects at the
routine fetal examination at 18 weeks in a non-selected population // Ultrasound Obstet. Gynecol.
1995. V. 5. № 6. P. 372–380.
29. Chaoui R. The fourchamber view: four reasons
why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection
rate // Ultrasound Obstet. Gynecol. 2003. V. 22.
№1. P. 3–10.
30. Tegnander E., EikNes S.H., Linker D.T. Incorporating the four-chamber view of the fetal heart into
the secondtrimester routine fetal examination //
Ultrasound Obstet. Gynecol. 1994. V. 4. № 1.
P. 24–28.
31. Paladini D., Vassallo M., Tartaglione A., Lapadula C., Martinelli P. The role of tissue harmonic
imaging in fetal echocardiography // Ultrasound
Obstet. Gynecol. 2004. V. 23. № 2. P. 159–164.
32. Allan L.D., Crawford D.C., Chita S.K., Tynan M.J.
Prenatal screening for congenital heart disease //
Br. Med. J. 1986. V. 292. № 6537. P. 1717–1719.
33. Copel J.A., Pilu G., Green J., Hobbins J.C.,
Kleinman C.S. Fetal echocardiographic screening
for congenital heart disease: the importance of the
fourchamber view // Am. J. Obstet. Gynecol.
1987. V. 157. № 3. P. 648–655.
34. Di Salvo D.N., Brown D.L., Doubilet P.M., Benson C.B., Frates M.C. Clinical significance of isolated fetal pericardial effusion // J. Ultrasound
Med. 1994. V. 13. № 4. P. 291–293.
35. Yoo S.J., Min J.Y., Lee Y.H. Normal pericardial
fluid in the fetus: color and spectral Doppler analysis // Ultrasound Obstet. Gynecol. 2001. V. 18.
№3. P. 248–252.
36. Copel J.A., Liang R.I., Demasio K., Ozeren S.,
Kleinman C.S. The clinical significance of the
irregular fetal heart rhythm // Am. J. Obstet.
Gynecol. 2000. V. 182. № 4. P. 813–817.
37. Comstock C.H. Normal fetal heart axis and position // Obstet. Gynecol. 1987. V. 70. № 2.
P. 255–259.
38. Smith R.S., Comstock C.H., Kirk J.S., Lee W. Ultrasonographic left cardiac axis deviation: a marker
for fetal anomalies // Obstet. Gynecol. 1995. V. 85.
№ 2. P. 187–191.
39. Sharland G.K., Chan K.Y., Allan L.D. Coarctation
of the aorta: difficulties in prenatal diagnosis //
Br. Heart J. 1994. V. 71. № 1. P. 70–75.
40. Kirk J.S., Comstock C.H., Lee W., Smith R.S.,
Riggs T.W., Weinhouse E. Fetal cardiac asymmetry: a marker for congenital heart disease // Obstet.
Gynecol. 1999. V. 93. № 2. P. 189–192.
41. Bromley B., Estroff J.A., Sanders S.P., Parad R.,
Roberts D., Frigoletto F.D. Jr., Benacerraf B.R.
Fetal echocardiography: accuracy and limitations
in a population at high and low risk for heart
defects // Am. J. Obstet. Gynecol. 1992. V. 166.
№5. P. 1473–1481.
42. Kirk J.S., Riggs T.W., Comstock C.H., Lee W.,
Yang S.S., Weinhouse E. Prenatal screening for
cardiac anomalies: the value of routine addition of
the aortic root to the fourchamber view // Obstet.
Gynecol. 1994. V. 84. № 3. P. 427–431.
43. DeVore G. The aortic and pulmonary outflow tract
screening examination in the human fetus // J.
Ultrasound Med. 1992. V. 11. № 7. P. 345–348.
44. Yoo S.J., Lee Y.H., Kim E.S., Ryu H.M., Kim M.Y.,
Choi H.K., Cho K.S., Kim A. Three-vessel view
of the fetal upper mediastinum: an easy means of
detecting abnormalities of the ventricular outflow
tracts and great arteries during obstetric screening // Ultrasound Obstet. Gynecol. 1997. V. 9. № 3.
P. 173–182.
45. Yoo S.J., Lee Y.H., Cho K.S. Abnormal three-vessel
view on sonography: a clue to the diagnosis of congenital heart disease in the fetus // Am. J.
Roentgenol. 1999. V. 172. № 3. P. 825–830.
46. Vinals F., Heredia F., Giuliano A. The role of the
three vessels and trachea view (3VT) in the diagnosis of congenital heart defects // Ultrasound
Obstet. Gynecol. 2003. V. 22. № 4. P. 358–367.
47. Yagel S., Arbel R., Anteby E.Y., Raveh D., Achiron R. The three vessels and trachea view (3VT)
in fetal cardiac scanning // Ultrasound Obstet.
Gynecol. 2002. V. 20. № 4. P. 340–345.
48. Vettraino I.M., Lee W., Bronsteen R.A., Comstock C.H. Sonographic evaluation of the ventricular cardiac outflow tracts // J. Ultrasound Med.
2005. V. 24. № 4. P. 566.
49. Stumpflen I., Stumpflen A., Wimmer M., Bernaschek G. Effect of detailed fetal echocardiography
as part of routine prenatal ultrasonographic screening on detection of congenital heart disease // Lancet. 1996. V. 348. № 9031. P. 854–857.
50. Small M., Copel J.A. Indications for fetal echocardiography // Pediatr. Cardiol. 2004. V. 25. № 3.
P. 210–222.
51. Hyett J., Moscoso G., Papapanagiotou G., Perdu M.,
Nicolaides K.H. Abnormalities of the heart and
great arteries in chromosomally normal fetuses
with increased nuchal translucency thickness at
11–13 weeks of gestation // Ultrasound Obstet.
Gynecol. 1996. V. 7. № 4. P. 245–250.
52. Hyett J.A., Perdu M., Sharland G.K., Snijders R.S.,
Nicolaides K.H. Increased nuchal translucency at
10–14 weeks of gestation as a marker for major cardiac defects // Ultrasound Obstet. Gynecol. 1997.
V. 10. № 4. P. 242–246.
53. Mavrides E., CobianSanchez F., Tekay A., Moscoso G., Campbell S., Thilaganathan B., Carvalho J.S.
Limitations of using firsttrimester nuchal translucency measurement in routine screening for major
congenital heart defects // Ultrasound Obstet.
Gynecol. 2001. V. 17. № 2. P. 106–110.
54. Ghi T., Huggon I.C., Zosmer N., Nicolaides K.H.
Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype // Ultrasound Obstet. Gynecol.
2001. V. 18. № 6. P. 610–614.

Cardiac Screening Examination of the Fetus: Guidelines for Performing the “Basic” and “Extended Basic” Cardiac Scan

Keywords: